These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 7034478

  • 21. Which vasodilator drug in patients with chronic heart failure? A randomised comparison of captopril and hydralazine.
    Schofield PM, Brooks NH, Lawrence GP, Testa HJ, Ward C.
    Br J Clin Pharmacol; 1991 Jan; 31(1):25-32. PubMed ID: 2015167
    [Abstract] [Full Text] [Related]

  • 22. Hemodynamic and metabolic effects of vasodilator therapy for heart failure in acute myocardial infarction.
    Kodama K, Koretsune Y, Nanto S, Taniura K.
    Jpn Circ J; 1984 Apr; 48(4):380-7. PubMed ID: 6425527
    [Abstract] [Full Text] [Related]

  • 23. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Ghose JC, Chakraborty S, Mondal M, Bhandari B.
    J Assoc Physicians India; 1993 May; 41(5):269-71. PubMed ID: 8300456
    [Abstract] [Full Text] [Related]

  • 24. Effect of enalapril, hydralazine plus isosorbide dinitrate, and prazosin on hospitalization in patients with chronic congestive heart failure. The V-HeFT VA Cooperative Studies Group.
    Loeb HS, Johnson G, Henrick A, Smith R, Wilson J, Cremo R, Cohn JN.
    Circulation; 1993 Jun; 87(6 Suppl):VI78-87. PubMed ID: 8500244
    [Abstract] [Full Text] [Related]

  • 25. [Vasodilator agents in the therapeutic arsenal of cardiac insufficiency].
    Lavitola Pde L, Higa SS.
    Rev Paul Med; 1986 Jun; 104(3):136-40. PubMed ID: 3563266
    [No Abstract] [Full Text] [Related]

  • 26. Afterload reduction and cardiac performance. Physiologic basis of systemic vasodilators as a new approach in treatment of congestive heart failure.
    Mason DT.
    Am J Med; 1978 Jul; 65(1):106-25. PubMed ID: 99030
    [Abstract] [Full Text] [Related]

  • 27. Effects of captopril and a combination of hydralazine and isosorbide dinitrate on myocardial sympathetic tone in patients with severe congestive heart failure.
    Daly P, Rouleau JL, Cousineau D, Burgess JH, Chatterjee K.
    Br Heart J; 1986 Aug; 56(2):152-7. PubMed ID: 3524637
    [Abstract] [Full Text] [Related]

  • 28. Results of long-term vasodilator therapy in patients with refractory congestive heart failure.
    Walsh WF, Greenberg BH.
    Circulation; 1981 Sep; 64(3):499-505. PubMed ID: 7261282
    [Abstract] [Full Text] [Related]

  • 29. Effect of direct vasodilation with hydralazine versus angiotensin-converting enzyme inhibition with captopril on mortality in advanced heart failure: the Hy-C trial.
    Fonarow GC, Chelimsky-Fallick C, Stevenson LW, Luu M, Hamilton MA, Moriguchi JD, Tillisch JH, Walden JA, Albanese E.
    J Am Coll Cardiol; 1992 Mar 15; 19(4):842-50. PubMed ID: 1545080
    [Abstract] [Full Text] [Related]

  • 30. [Orally active vasodilators in the management of chronic treatment-resistant cardiac failure (author's transl)].
    Wirtzfeld A, Klein G, Himmler FC, Schmidt G, Kutschera I, Sauer E.
    Dtsch Med Wochenschr; 1980 Oct 03; 105(40):1379-83. PubMed ID: 7449633
    [Abstract] [Full Text] [Related]

  • 31. Effect of vasodilator therapy on mortality in chronic congestive heart failure.
    Cohn JN.
    Eur Heart J; 1988 Jan 03; 9 Suppl A():171-3. PubMed ID: 3044793
    [Abstract] [Full Text] [Related]

  • 32. [Limitations of long-term treatment with vasodilator agents in increasing maximum functional capacity in patients with left ventricular insufficiency].
    Gronda E, Mafrici A, Ferrari D, Cataldo G, Salvadè P, Pirelli S, Mauri F, Faletra F, Carù B.
    G Ital Cardiol; 1981 Jan 03; 11(6):803-11. PubMed ID: 7319186
    [No Abstract] [Full Text] [Related]

  • 33. [Vasodilator therapy in cardiac failure].
    Akatsuka N.
    Nihon Rinsho; 1993 May 03; 51(5):1276-80. PubMed ID: 8101237
    [Abstract] [Full Text] [Related]

  • 34. Acute hemodynamic responses to vasodilator therapy in congestive heart failure.
    Ribner HS, Bresnahan D, Hsieh AM, Silverman R, Tommaso C, Coath A, Askenazi J.
    Prog Cardiovasc Dis; 1982 May 03; 25(1):1-42. PubMed ID: 6287524
    [No Abstract] [Full Text] [Related]

  • 35. Vasodilator therapy for chronic congestive heart failure.
    Abrams J.
    JAMA; 1985 Dec 06; 254(21):3070-4. PubMed ID: 3932697
    [No Abstract] [Full Text] [Related]

  • 36. Is there a drug of choice for vasodilator therapy in patients with refractory heart failure?
    Packer M.
    Chest; 1980 Jan 06; 77(1):7-9. PubMed ID: 7351152
    [No Abstract] [Full Text] [Related]

  • 37. [Modern vasodilator medication in refractory cardiac insufficiency].
    Stanciu L, Branea I, Riviş I, Radivoievici A, Mancaş S, Păunescu A.
    Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1983 Jan 06; 35(2):129-34. PubMed ID: 6139858
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40. Isosorbide Dinitrate, With or Without Hydralazine, Does Not Reduce Wave Reflections, Left Ventricular Hypertrophy, or Myocardial Fibrosis in Patients With Heart Failure With Preserved Ejection Fraction.
    Zamani P, Akers S, Soto-Calderon H, Beraun M, Koppula MR, Varakantam S, Rawat D, Shiva-Kumar P, Haines PG, Chittams J, Townsend RR, Witschey WR, Segers P, Chirinos JA.
    J Am Heart Assoc; 2017 Feb 20; 6(2):. PubMed ID: 28219917
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.